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Abstract. 
 
Tenascin-C (TN-C) is induced in pulmonary 
vascular disease, where it colocalizes with proliferating 
smooth muscle cells (SMCs) and epidermal growth fac-
tor (EGF). Furthermore, cultured SMCs require TN-C 
for EGF-dependent growth on type I collagen. In this 
study, we explore the regulation and function of TN-C 
in SMCs. We show that a matix metalloproteinase 
(MMP) inhibitor (GM6001) suppresses SMC TN-C 
expression on native collagen, whereas denatured col-
 
lagen promotes TN-C expression in a 
 
b
 
3 integrin–
dependent manner, independent of MMPs. Floating 
type I collagen gel also suppresses SMC MMP activity 
and TN-C protein synthesis and induces apoptosis, in 
the presence of EGF. Addition of exogenous TN-C to 
SMCs on floating collagen, or to SMCs treated with 
GM6001, restores the EGF growth response and “res-
cues” cells from apoptosis. The mechanism by which 
TN-C facilitates EGF-dependent survival and growth 
was then investigated. We show that TN-C interactions 
 
with 
 
a
 
v
 
b
 
3
 
 integrins modify SMC shape, and EGF-
dependent growth. These features are associated with 
redistribution of filamentous actin to focal adhesion 
complexes, which colocalize with clusters of EGF-Rs, 
tyrosine-phosphorylated proteins, and increased activa-
tion of EGF-Rs after addition of EGF. Cross-linking 
SMC 
 
b
 
3
 
 integrins replicates the effect of TN-C on 
EGF-R clustering and tyrosine phosphorylation. To-
gether, these studies represent a functional paradigm 
for ECM-dependent cell survival whereby MMPs up-
regulate TN-C by generating 
 
b
 
3
 
 integrin ligands in type 
I collagen. In turn, 
 
a
 
v
 
b
 
3
 
 interactions with TN-C alter 
SMC shape and increase EGF-R clustering and EGF-
dependent growth. Conversely, suppression of MMPs 
downregulates TN-C and induces apoptosis.
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1. 
 
Abbreviations used in this paper
 
: ECM, extracellular matrix; EGF-R,
epidermal growth factor receptor; MMP, matrix metalloproteinase; SFM,
serum-free medium; SMC, smooth muscle cell; TN-C, tenascin-C.
 
T
 
enascin-c 
 
(TN-C)
 
1
 
 is an extracellular matrix
(ECM) glycoprotein that is prominent in embryonic
and adult tissues that are actively remodeling (Chi-
quet-Ehrismann et al., 1995), where it is often coexpressed
with matrix metalloproteinases (MMPs), a family of zinc-
dependent ECM-degrading enzymes (Hedin et al., 1991;
Talhouk et al., 1991; Jones et al., 1995; Latijnhouwers et al.,
1996; Vaalamo et al., 1996). For example, during postlacta-
tional involution of the mammary gland, increased levels
of TN-C and stromelysin-1 directly contribute to the loss
of tissue-specific gene expression (Sympson et al., 1994;
Jones et al., 1995) and the onset of apoptosis (Boudreau et
al., 1995
 
a
 
, 1996), which together characterize this stage of
development (Strange et al., 1992). In mature blood ves-
sels subjected to experimental balloon catheter injury, TN-C
and MMP-2 expression are induced before the develop-
ment of occlusive neointimal lesions (Mackie et al., 1992;
Bendeck et al., 1994; Hedin et al., 1991; Zempo et al., 1994;
Strauss et al., 1996), indicating that these proteins may also
share a common function during vascular remodeling. In
addition, since TN-C and MMP-2 each have the capacity
to bind the 
 
a
 
v
 
b
 
3
 
 integrin (Prieto et al., 1993; Sriramarao et
al., 1993; Brooks et al., 1996) and their expression is sensi-
tive to treatments that alter the integrity of the actin cy-
toskeleton (Aggeler et al., 1984; Chiquet-Ehrismann et al.,
1994), it is possible that these proteins are regulated in an
interdependent manner. Indeed, studies by Tremble et al.
(1994) have demonstrated that TN-C–supplemented fi-
bronectin matrices stimulate MMP expression in cultured
rabbit synovial fibroblasts. Evidence that MMPs may reg-
ulate TN-C in a reciprocal manner, however, has not been
forthcoming.
A functional role for TN-C in modulating vascular
smooth muscle cell (SMC) proliferation has been sug-
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gested by studies demonstrating increased TN-C synthesis
after wounding injury in vivo (Hedin et al., 1991), or by
treatment with vasoactive peptides and growth factors in
tissue culture (Mackie et al., 1992; Sharifi et al., 1992). Our
recent studies in rat and human hypertensive pulmonary
arteries (Jones and Rabinovitch, 1996; Jones et al., 1997),
as well as those in vessels from spontaneously hyperten-
sive rats and human vein grafts (Hahn et al., 1995; Chen et
al., 1996), have shown that TN-C colocalizes with prolifer-
ating SMCs, as well as EGF (Jones et al., 1997). An addi-
tional link between TN-C expression and growth factor–
dependent SMC proliferation was also provided by tissue
culture studies that demonstrated that TN-C potentiates
bFGF-dependent SMC growth and is critical for EGF-
dependent SMC growth on type I collagen (Jones and
Rabinovitch, 1996). Similarly, End et al. (1992) reported
that TN-C collaborates with EGF to promote growth of
several cell types, including fibroblasts and SMCs isolated
from spontaneously hypertensive rats.
Although the mechanism by which TN-C cooperates
with soluble growth factors to generate a mitogenic re-
sponse in normal SMCs is not understood, recent studies
with other cell types show that integrin and growth factor
receptor signaling components may accumulate on the ac-
tin-based cytoskeletal scaffold to form a specialized focal
adhesion complex (Miyamato et al., 1995
 
a
 
,
 
b
 
; Plopper et
al., 1995), where they collaborate to regulate activation of
mitogen-activated protein kinases and receptor tyrosine
kinases, including the EGF receptor (EGF-R) (Miyamoto
et al., 1996). Mechanistically, epidermal growth factor re-
ceptors have been shown to directly interact with actin
(den Hartigh et al., 1992), and from a functional stand-
point, this association greatly enhances activation of the
EGF-R and its downstream substrates (Diakonova et al.,
1995; Gronowski and Bertics, 1995). Since TN-C has been
shown to alter the integrity of the actin cytoskeleton (Mur-
phy-Ullrich et al., 1991; Chung et al., 1996), it is therefore
possible that this ECM component modulates EGF-R sig-
naling through its effects on the actin cytoskeleton and as-
sociated focal adhesion components.
In this study, we first investigated the relationships be-
tween MMPs, TN-C, and EGF-dependent SMC survival.
Using SMCs cultured on attached and floating collagen
gels as a model system, we show that net MMP activity,
TN-C expression, and SMC survival are suppressed on
floating collagen gels. Furthermore, we demonstrate that
 
b
 
3
 
 integrins support basal levels of TN-C expression on at-
tached native type I collagen and that a specific inhibitor
of MMPs (GM6001) suppresses this expression and limits
cell survival. Moreover, addition of exogenous TN-C to
SMC cultures in which MMP activity and TN-C produc-
tion have been suppressed supports SMC survival and
EGF-dependent growth. Culturing SMCs on denatured
collagen obviates the requirement for MMPs and directly
promotes TN-C expression in a 
 
b
 
3
 
 integrin–dependent
manner. We next explored the mechanism by which TN-C
facilitates this effect, and we show that TN-C binding to
the 
 
a
 
v
 
b
 
3
 
 integrin supports EGF-dependent SMC growth,
and that this interaction leads to changes in cell morphol-
ogy underscored by the reorganization of the actin cyto-
skeleton. This structural alteration is accompanied by
clustering of EGF-Rs and accumulation of tyrosine-phos-
 
phorylated proteins at the cell periphery within focal ad-
hesion complexes. Addition of EGF to these physically
and biochemically primed cells leads to increased SMC
EGF-R activation and growth. Together, these data pro-
vide a functional paradigm for the regulation of TN-C by
MMPs in actively restructuring tissues and for how this
ECM component interacts with 
 
b
 
3
 
 integrins to promote
EGF-dependent growth and survival.
 
Materials and Methods
 
Cell Culture
 
Vascular SMCs were isolated from pulmonary arteries of 300-g adult male
Sprague-Dawley rats. Briefly, arteries were harvested from anaesthetized
animals and placed in cold sterile PBS, pH 7.6. Endothelium was removed
by gently scraping the lumenal surface with a scalpel blade, and the adven-
titia was also removed from the vessel. The medial layer was minced using
scalpel blades and incubated at 37
 
8
 
C in medium 199 (M199; GIBCO BRL,
Gaithersburg, MD) supplemented with 0.1% collagenase I (Sigma Chemi-
cal Co., St. Louis, MO.), and 0.1% BSA (Boehringer-Mannheim, Laval
Canada) for 1 h with gentle rotation. Tissue was collected by centrifugation
at 300 
 
g
 
, resuspended in M199/collagenase I solution, and incubated over-
night at 37
 
8
 
C with gentle rotation. Smooth muscle cells were harvested by
centrifugation and were routinely maintained in M199 containing 10%
heat-inactivated FBS (Intergen, Purchase, NY), 10 U/ml penicillin G so-
dium, 10 mg/ml streptomycin sulfate, 0.25 mg/ml amphotericin B, and 0.1
mg/ml gentamicin sulfate (GIBCO BRL). Cells were passaged by
trypsinization using 0.05% trypsin/EDTA (GIBCO BRL). Vascular
SMCs were identified by their characteristic hills-and-valley morphology
and immunohistochemical staining for 
 
a
 
-smooth muscle actin.
Collagen gels were prepared based on methods that have been previ-
ously described (Jones and Rabinovitch., 1996). Briefly, 0.8 ml of a 3.1 mg/
ml solution of bovine dermal type I collagen (Vitrogen 100; Collagen
Corp., CA), 0.1 ml of 0.1 M NaOH, and 0.1 ml of 10
 
3
 
 PBS were mixed at
4
 
8
 
C for a final collagen concentration of 2.48 mg/ml. To determine the ef-
fect of TN-C on SMC behavior, neutralized collagen was supplemented
with 15 
 
m
 
g/ml of human TN-C protein (Chemicon International, Temec-
ula, CA). Fibrillogenesis was initiated overnight in a humid 5% CO
 
2
 
 envi-
ronment at 37
 
8
 
C, and the gels were rinsed extensively (three times for 3 h)
with M199 containing 0.1% BSA before use. Confluent cultures of rat PA
SMCs were serum starved in M199/0.1% BSA for 48 h. Smooth muscle
cells were collected by trypsinization and centrifugation, and cell number
was determined using an improved Neubauer hemocytometer (American
Optical, Buffalo, NY). Cell pellets were resuspended in M199/0.1% BSA
plus 0.5% serum, and a 1-ml aliquot of SMCs was seeded onto the surface
of each gel. 6 h later, cells were rinsed in M199 and were thereafter cul-
tured in M199/0.1% BSA.
 
Smooth Muscle Growth on Collagen Gels
 
We used collagen gels and heat-denatured collagen to determine the inter-
relationships between TN-C, MMP activity, 
 
b
 
3
 
 integrins, and EGF-depen-
dent SMC survival and growth. For these experiments, 2 
 
3
 
 10
 
4
 
 cells were
plated on collagen gels as described above. For anti-
 
a
 
v
 
b
 
3
 
 antibody block-
ing studies, SMCs were plated on collagen gels in the presence of 15 
 
m
 
g/ml
LM609 monoclonal antibody (a kind gift from Dr. David Cheresh, Scripps
Research Institute, La Jolla, CA) or with 15 
 
m
 
g/ml of control IgG (DAKO
Corp., Carpenteria, CA). For 
 
b
 
3
 
 integrin studies on native and denatured
collagen, SMCs were plated in the presence of 25 
 
m
 
g/ml anti-
 
b
 
3 mono-
clonal antibody (PharMingen, San Diego, CA) or with 25 
 
m
 
g/ml of control
IgG (DAKO Corp.). For MMP inhibitor studies, 1–2 
 
m
 
m GM6001 (a kind gift
from Dr. Stu Sweidler, Glycomed, Alameda, CA) in DMSO, or an equivalent
volume of DMSO alone, was added to cultures 24 h after plating. GM6001
(
 
N
 
-[2(R)-2-(hydroxamidocarbonylmethyl)-4-methylpentanoyl]-
 
l
 
-tryp-
t ophane methylamide) is a noncytotoxic synthetic inhibitor that is specific
for MMPs. The hydroxamic group of GM6001 binds to the critical active
site zinc atom present in MMPs. In addition, the isobutyl group and tryp-
tophan side chain of GM6001 also binds to subsites on MMPs, which nor-
mally bind side chains of ECM proteins (Galardy, 1993; Boudreau et al.,
1995
 
a
 
; Strauss et al., 1996). For assessment of the effects of heat denatured
collagen, cells were plated on 50 
 
m
 
g of type I collagen/35-mm-diam dish
that had been boiled for 30 min with 0.02 M acetic acid, and then air dried 
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to the bottom of each dish. Before plating cells, collagen substrates were
rinsed extensively, (three times for 1 h) with M199/0.1% BSA. To “float”
the collagen gels, we detached them from the plastic substratum 24 h after
plating using a spatula. 24 h after plating, cells were cultured in M199/
0.1% BSA either with or without 50 ng/ml EGF (GIBCO BRL). The
number of cells retained on collagen gels was determined 72 h after plat-
ing. The dose of EGF chosen to be stimulatory to SMC growth was deter-
mined in pilot studies and previously published by our group (Jones and
Rabinovitch, 1996). All experiments were performed in triplicate. Attach-
ment efficiencies were determined by counting the number of cells in the
medium using a hemocytometer or Coulter counter. The number of at-
tached cells (number of cells seeded 
 
2
 
 number of cells in the medium)
was expressed as a percentage of the number of cells seeded. To assess the
number of cells retained on collagen, gels were digested with 1 mg/ml col-
lagenase type II (Sigma Chemical Co.) for 1 h at 37
 
8
 
C. Free cells were pel-
leted by centrifugation at 4
 
8
 
C for 10 min at 300 
 
g
 
 and suspended in PBS
containing 0.05% trypsin, and cell number was determined by counting al-
iquots in triplicate using a hemocytometer.
 
Detection of Matrix Metalloproteinases
 
Conditioned medium was collected from cells maintained on attached or
floating collagen gels for 4, 8, 12, and 24 h in M199 with 50 ng/ml EGF. For
each culture and at every time point, SMCs were rinsed gently three times
with culture medium and then reincubated with 1 ml of fresh medium. At
the designated time points, conditioned medium was harvested from the
cultures, and equal volumes of medium were lyophilized overnight. Con-
ditioned medium was mixed 3:1 (vol/vol) with 4
 
3
 
 sample buffer (10%
SDS, 25% glycerol in 150 mM Tris-Cl, pH 6.8) and separated on nonre-
ducing 10% polyacrylamide gels that contained 0.1% gelatin (Sigma
Chemical Co.). After electrophoresis, gels were soaked in 2.5% Triton
X-100 to remove SDS and incubated in substrate buffer (50 mM Tris-Cl,
pH 7.5, 5 mM CaCl
 
2
 
) for 18 h at 37
 
8
 
C. The gels were then stained with
Coomassie blue R250 (Bio-Rad Labs, Hercules, CA). Gelatinases appear
as a clear zone on a blue background. To demonstrate the ability of
GM6001 to inhibit MMPs, we incubated gelatin zymograms in substrate
buffer containing 2 
 
m
 
M of this inhibitor. This treatment abolished MMP
activity. For detection of the pro-form of MMP-2, 20 
 
m
 
g of total protein
contained in conditioned medium harvested from SMCs cultured on at-
tached and floating collagen for 24 h in serum-free medium (SFM) was
subjected to SDS-PAGE electrophoresis. Proteins were electrophoreti-
cally transferred to nylon membranes, blocked for 1 h at 37
 
8
 
C in wash
buffer (10 mM Tris, pH 7.5, 10 mM NaCl, and 0.1% Tween-20), contain-
ing 0.1% BSA and 1% normal goat serum (Sigma Chemical Co.), and
then with an anti–MMP-2 rabbit polyclonal antisera (a kind gift from Drs.
M. Silverman and M. Ailenburg, Department of Medicine, University of
Toronto, Toronto, Canada) diluted 1:200 in wash buffer for 30 min at
37
 
8
 
C. To detect MMP-2, membranes were then incubated with a horserad-
ish peroxidase–conjugated goat anti–rabbit secondary antibody (GIBCO
BRL) diluted 1:3,000 in wash buffer, rinsed in wash buffer three times for
15 min, visualized by enhanced chemiluminescence (ECL kit; Amershan
Corp., Arlington Heights, IL), and exposed to film (X-Omat; Kodak,
Rochester, NY).
 
Immunofluorescent Detection of
Phosphorylated Proteins, Actin, Epidermal Growth 
Factor Receptors, and Vinculin
 
For immunofluorescent studies, serum starved SMCs were cultured on
glass coverslips (12 mm, No.1 thickness) coated with 2.48 mg/ml of neu-
tralized type I collagen (
 
1
 
/
 
2
 
 15 
 
m
 
g/ml TN) in M199/0.1% BSA. For actin,
EGF-Rs, and tyrosine-phosphorylated proteins, cells were exposed to 50
ng/ml EGF in M199/0.1% BSA for 30 min or subjected to control treat-
ment with M199/0.1% BSA alone. To determine the effects of blocking
the 
 
b
 
3
 
 integrin on EGF-R distribution, SMCs were preincubated with 25
 
m
 
g/ml anti–rat 
 
b
 
3
 
 integrin monoclonal antibody (CD61; PharMingen) be-
fore plating on collagen- and TN-C–enriched substrates. At the appropri-
ate time point, cells were rinsed in PBS and then fixed. For detection of
F-actin, SMCs were fixed with extraction buffer (60 mM Pipes, 25 mM
Hepes, 10 mM EDTA, 2 mM MgCl
 
2
 
, pH 6.9) supplemented with 0.2%
Triton X-100 for 5 min at 4
 
8
 
C. Smooth muscle cells were then washed
three more times for 5 min in extraction buffer without Triton X-100.
Fixed cells were incubated with 2.5 U of rhodamine-phalloidin (Molecular
Probes, OR) in PBS for 20 min at 37
 
8
 
C before rinsing briefly with PBS. To
detect EGF-Rs, tyrosine-phosphorylated proteins, and vinculin, SMCs
were fixed in 2% paraformaldehyde (Sigma Chemical Co.) for 10 min at
room temperature and rinsed in PBS containing 0.1 M glycine for 30 min.
For tyrosine-phosphorylated proteins and vinculin, SMCs were permeabil-
ized with 0.2% Triton X-100 in PBS for 5 min and washed three more
times. The fixed cells were incubated for 1 h at 37
 
8
 
C in wash buffer (PBS/
1% BSA), supplemented with 10% normal goat serum for EGF-Rs, and
then incubated for 1 h at 37
 
8
 
C with anti-EGF-R antisera (RK-2, diluted
1:100; a kind gift from Dr. Irit Lax, New York University Medical Center,
New York), antiphosphotyrosine monoclonal antibody (clone 4G10; 5 
 
m
 
g/
ml; Upstate Biotechnology Inc., Lake Placid, NY), antivinculin mono-
clonal antibody (diluted 1:50; Sigma Chemical Co.), or appropriate preim-
mune sera and IgG controls in wash buffer. After being washed three
times, coverslips were incubated for 1 h at 37
 
8
 
C either with fluorescein-
conjugated goat anti–rabbit antibody (diluted 1:100; Sigma Chemical Co.)
or with goat anti–mouse antibody (diluted 1:100; Sigma Chemical Co.).
For double immunofluorescent staining experiments, all cells were fixed
in 2% paraformaldehyde. For vinculin and EGF-Rs, cells were permeabil-
ized in methanol for 2 min and were then air dried for 1 h at room temper-
ature. For vinculin, tyrosine-phosphorylated proteins, and F-actin, fixed
cells were washed in PBS containing 0.2% Triton X-100. All cells were
then washed with PBS/0.1 M glycine and were sequentially incubated with
appropriate antisera, antibodies, or rhodamine-phalloidin as described
above. After washing, all coverslips were mounted onto glass slides using
Antifade reagent (Molecular Probes). Observations and photomicro-
graphs were obtained with a fluorescent microscope (Olympus Corp.,
Lake Success, NY) using epifluorescence.
 
Biochemical Analysis of
Tyrosine-phosphorylated Proteins, Tenascin-C, and 
Epidermal Growth Factor Receptors
 
Tyrosine-phosphorylated proteins were analyzed by immunoblotting
whole cell lysates, SMC membrane–enriched protein fractions, or EGF-R
immunoprecipitates with a horseradish peroxidase–conjugated antiphos-
photyrosine (RC20H; Transduction Labs, Lexington, KY). 4 
 
3
 
 10
 
6
 
 SMCs
cultured for 24 h on 10-cm-diam collagen gels (
 
1
 
/
 
2
 
 TN-C) were treated
with EGF (50 ng/ml) for 10 and 30 min or were further incubated in M199/
0.1% BSA alone. Tenascin-C protein expression on collagen gels was as-
sessed by immunoblotting equal numbers (2 
 
3
 
 10
 
4
 
) of cell lysates with an
anti–chicken TN-C rabbit polyclonal antisera (pK7; gift from Dr. M.
Schachner, Swiss Federal Institute of Technology, Zurich, Switzerland).
To determine the effect of the 
 
b
 
3
 
 integrin on TN-C–dependent EGF-R
phosphorylation, SMCs were cultured on TN-C–supplemented collagen
gels with 25 
 
m
 
g/ml of anti–rat 
 
b
 
3
 
 integrin monoclonal antibody (CD61;
PharMingen) or with control IgG (DAKO Corp.).
To enrich for membrane proteins, SMCs were harvested at the appro-
priate time points in ice-cold buffer containing 50 mM Hepes, 1 mM benz-
amidine, 1 mM PMSF, 1 
 
m
 
g/ml aprotinin, 5 
 
m
 
g/ml leupeptin, 2 mM NaF, 2
mM Na
 
3
 
VO
 
4
 
, 1 mM MgCl
 
2
 
, and 0.25 M sucrose, pH 7.4 at 4
 
8
 
C. Cells were
homogenized with a Dounce B glass homogenizer (60 strokes), and intact
cells and nuclei were sedimented by centrifugation at 3,000 
 
g
 
 for 5 min at
4
 
8
 
C. The resulting supernatants were centrifuged at 100,000 
 
g
 
 for 1 h at
4
 
8
 
C, and the membrane-enriched pellet was solubilized by sonication in
homogenization buffer supplemented with 1% Triton X-100. Protein con-
tent was determined using the Bio-Rad protein assay according to the
manufacturer’s instructions. For EGF-R immunoprecipitation experi-
ments, 15 
 
m
 
g of membrane-enriched protein, resuspended in 0.5 ml RIPA
lysis buffer (25 mM Tris, pH 7.2, 0.1% SDS, 1% Triton X-100, 1% sodium
deoxycholate, 150 mM NaCl, and 1 mM EDTA) containing 1 mM benz-
amidine, 1 mM PMSF, 1 
 
m
 
g/ml aprotinin, 5 
 
m
 
g/ml leupeptin, 2 mM NaF,
and 2 mM Na
 
3
 
VO
 
4
 
 was precleared with normal rabbit IgG and protein
A–Sepharose (Sigma Chemical Co.) for 1 h at 4
 
8
 
C. Supernatants were
then incubated for 1 h at 4
 
8
 
C with the rabbit polyclonal anti–EGF-R antibody
diluted 1:400 in RIPA buffer and precipitated with protein A–Sepharose.
Pellets were washed three times with ice-cold RIPA buffer and once in 50
mM Tris, pH 7.4. Membrane fractions (15 
 
m
 
g) and EGF-R immunoprecip-
itates were boiled in reducing sample buffer containing 0.2 M Tris-HCl,
pH 8.8, 18% glycerol, 4% SDS, 0.01% bromophenol blue, and 10%
 
b
 
-mercaptoethanol. All samples were separated in 7% SDS–polyacryla-
mide gels. Proteins were transferred to Immobilon polyvinyl fluoride
membranes (Millipore Corp., Milford, MA), and these were blocked for
1 h at 37
 
8
 
C in wash buffer (10 mM Tris, pH 7.5, 10 mM NaCl, and 0.1%
Tween-20), supplemented with 0.1% BSA. To detect tyrosine-phosphory-
lated proteins, blots were incubated for 30 min with horseradish peroxi-
dase–conjugated antiphosphotyrosine antibody, diluted 1:2,500 in wash 
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buffer. To detect TN-C protein, membranes were sequentially incubated
with anti–TN-C antisera and a horseradish peroxidase–conjugated goat
anti–rabbit secondary antibody (GIBCO BRL) diluted 1:5,000 in wash
buffer. Thereafter, all membranes were rinsed in wash buffer three times
for 15 min, and tyrosine-phosphorylated and TN-C proteins were visual-
ized by enhanced chemiluminescence (Amersham ECL kit) before expo-
sure to film (X-Omat; Kodak).
 
b
 
3
 
 Integrin Cross-Linking Studies
 
To cluster 
 
b
 
3
 
 integrins, SMCs were first cultured on collagen gels and were
then washed gently with medium and incubated with 150 
 
m
 
g/ml anti-
 
b
 
3
 
monoclonal antibody (PharMingen) diluted in M199/0.1% BSA for 60
min. The SMCs were then rinsed with medium and incubated either with
20 
 
m
 
g/ml of goat anti–mouse IgG F(ab
 
9
 
)
 
2
 
 fragment (ICN Biomedicals,
Inc., Costa Mesa, CA) or with medium alone for 60 min at 37
 
8
 
C. For ty-
rosine-phosphorylation studies, SMCs were rinsed in medium and treated
with 50 ng/ml EGF for 10 or 30 min. Control cultures were maintained in
M199/0.1% BSA. Epidermal growth factor receptor immunoprecipitates
were analyzed by immunoblotting with antiphosphotyrosine antibodies as
described above.
In these studies, we also used immunofluorescence to demonstrate the
clustering of 
 
b
 
3
 
 integrins. Accordingly, SMCs were rinsed in PBS and
fixed in acetone at 
 
2
 
20
 
8
 
C for 1 min. Cells were rehydrated in PBS,
blocked in 1% PBSA for 1 h at 37
 
8
 
C, and incubated with a fluorescein-
conjugated goat anti–mouse antibody diluted 1:100 in 1% PBSA for 30
min at 37
 
8C, before being washed and visualized by epifluorescence. In
these experiments, EGF-R distribution was also examined by immunoflu-
orescence as described above.
Immunoprecipitation of Epidermal Growth Factor 
Receptors and Tenascin-C Protein
For immunoprecipitation of radiolabeled EGF-R and TN-C proteins, 2.5
3 104 serum-starved SMCs were cultured for 24 h on collagen gels in 35-
mm-diam tissue culture dishes. To determine the effect of TN-C on EGF-R
synthesis, collagen gels were supplemented with 15 mg/ml of TN-C. 24 h
after plating, SMCs were rinsed twice and incubated in cysteine/methio-
nine-free medium (ICN Biomedicals, Inc.) supplemented with 0.1% BSA
for 3 h and then pulse-labeled with 100 mCi/ml [35S]methionine/cysteine
translabel (ICN Biomedicals, Inc.) for 18 h. To determine the effects of
MMP inhibition on TN-C protein synthesis, cells were treated with 1- or
2-mm GM6001 in DMSO or with DMSO alone. Tissue culture medium
was collected in RIPA buffer and cleared by centrifugation. Total counts
per minute were normalized by TCA precipitation and equal counts per
minute (5 3 105 cpm/sample) were immunoprecipitated with 5 ml rabbit
polyclonal antisera raised against rat EGF-Rs (RK-2) or human TN-C
(GIBCO BRL). Immune complexes were precipitated with 25 ml protein
A–Sepharose (Sigma Chemical Co.), washed in 13 RIPA buffer, 50 mM
Tris, pH 7.4, and resuspended in 40 ml 23 SDS-PAGE sample buffer. Pro-
teins were separated on 6% SDS–polyacrylamide gels, fixed, dried, and
exposed to film (X-Omat; Kodak) for 3 d.
Apoptosis Assay
Internucleosomal DNA fragmentation is a characteristic of apoptosis and
was used to assess programmed cell death in SMCs cultured on attached
and floating type I collagen gels (1/2 TN-C). 48 h after floating, cells
were rinsed in PBS and incubated on ice with DNA lysis buffer (10 mM
Tris, pH 8, 100 mM NaCl, 2 mM EDTA, and 0.5% SDS) for 5 min with ro-
tation. Lysates were incubated with 1 mg/ml proteinase-K (Boehringer-
Mannheim Corp.) at 378C for 24 h with rotation. Genomic DNA was puri-
fied by sequential extraction with phenol/chloroform and was precipitated
overnight in ethanol at 2208C. DNA pellets were treated with 10 mg/ml
RNase A for 1 h at room temperature, and DNA was then quantified
based on optical density. 10 mg of genomic DNA was analyzed by electro-
phoresis through 1.2% agarose gels and visualized with ethidium bromide.
Statistical Analyses
All statistical assessments were compared by one-way analysis of variance
and Student Newman Keuls post hoc analysis. A P value of ,0.05 was
considered statistically significant. Mean values 6SEM are given in the
figures.
Results
Matrix Metalloproteinases and Tenascin-C
Are Coordinately Expressed in Vascular Smooth 
Muscle Cells
When chick embryo fibroblasts are cultured on attached
type I collagen gels, they express TN-C protein, whereas
culture on floating collagen leads to suppression of TN-C
expression (Chiquet-Ehrismann et al., 1994). Using this
culture method as a model system, we first compared SMC
morphology, TN-C production, and MMP activity and ex-
pression on attached and floating collagen gels. Within the
first few hours of releasing attached collagen gels into the
culture medium, SMCs lost their elongated morphology
and became rounded (Fig. 1 A). Immunoprecipitation of
radiolabeled TN-C protein from SMC conditioned me-
dium after 24 h (Fig. 1 B) showed that synthesis of two
TN-C protein isoforms, of apparent molecular masses 220
and 180 kD, was suppressed in SMCs cultured on floating
collagen when compared to those cultured on attached
collagen gels. No significant differences between the total
number of TCA precipitable counts were noted between
cells cultured on attached (1.10 3 106 cpm/culture, SEM 6
9.6 3 104, P , 0.05) versus floating collagen (1.13 3 106
cpm/culture, SEM 6 1.59 3 104, P , 0.05), indicating that
despite suppression of TN-C protein synthesis, general
protein synthesis at this time point was unaffected.
The production and activity of MMPs under these con-
ditions was then examined by gelatin substrate zymogra-
phy. Two proteins with approximate molecular masses of
68 and 57 kD were detected in conditioned medium har-
vested from SMCs cultured on attached and floating col-
lagen (Fig. 1 C). Densitometric analysis of these gelati-
nases showed that, relative to attached collagen, the
activities of the 68- and 57-kD gelatinase decreased with
time on floating collagen (Fig. 1 D). Under the denaturing
and nonreducing conditions used for zymography, the pro-
form of MMP-2 has an apparent molecular mass of 68 kD,
whereas the active form appears at z57 kD (Ailenburg et
al., 1993). Thus, our data indicate that the gelatinases de-
tected by zymography may represent MMP-2. Their iden-
tity as MMPs was substantiated by the abolishment of ge-
latinase activity after incubation of zymograms with EDTA
or GM6001 (data not shown) and Western immunoblot
analysis, which showed that expression of the pro-form of
MMP-2 (which migrates at 72 kD under denaturing and
reducing conditions) is suppressed on floating collagen
(Fig. 1 E).
Matrix Metalloproteinases and b3 Integrins Positively 
Regulate Smooth Muscle Cell Tenascin-C Production
Previous studies have shown that interstitial collagenases,
including MMP-2, are capable of degrading fibrillar native
type I collagen to generate collagen fragments (Aimes and
Quigley, 1995). At a functional level, this leads to expo-
sure of cryptic Arg-Gly-Asp (RGD) sites within the native
type I collagen molecule that bind the avb3 integrin receptor
to promote cell survival (Davis, 1992; Montgomery et al.,
1994). This integrin effect may also be achieved by culturing
cells on heat-denatured collagen (Montgomery et al., 1994).
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creased MMP expression and activity, we hypothesized that
degradation of native type I collagen by MMPs may upregu-
late SMC TN-C expression through b3 integrin ligation.
To first establish whether MMPs regulate TN-C expres-
sion, we cultured SMCs on attached type I collagen gels in
the presence of a specific MMP inhibitor, GM6001 (Galardy,
1993; Strauss et al., 1996). Immunoprecipitation of TN-C
from radiolabeled cell lysates showed that inhibition of
MMP activity results in suppression of TN-C protein syn-
thesis (Fig. 2 A). In addition, the ability of this inhibitor to
suppress TN-C protein synthesis is not due to cytotoxicity
since there were no significant differences between the to-
tal number of TCA precipitable counts in radiolabeled
control (3.18 3 106 cpm/culture, SEM 6 2.12 3 105, P ,
0.05) and GM6001-treated cultures (3.75 3 106 cpm/cul-
ture, SEM 6 1.63 3 105, P , 0.05) at the time point examined.
We next assessed TN-C protein expression on native
versus heat-denatured collagen. Western immunoblot analy-
sis showed that TN-C protein expression is upregulated on
denatured collagen (Fig. 2 B), and that this substrate obvi-
ated the need for MMPs (Fig. 2 C). To address whether
TN-C protein expression is regulated by b3 integrins, we
used a function-blocking anti-b3 antibody. Western immu-
noblots showed decreased TN-C protein expression in the
presence of the anti-b3 antibody when compared with IgG-
treated cultures on both native (Fig. 2 D) and proteolyzed
collagen. (Fig. 2 E).
Matrix Metalloproteinases and Tenascin-C Promote 
Smooth Muscle Cell Survival
Since MMPs regulate SMC TN-C protein synthesis on na-
tive type I collagen, and exogenous TN-C cooperates with
EGF to facilitate SMC growth on this substrate (Jones and
Rabinovitch, 1996), we next determined the functional
consequences of suppressing MMPs on EGF-dependent
SMC morphology, growth, and survival, in the presence
and absence of exogenously added TN-C. Inhibition of
MMPs with GM6001 in SMCs cultured on attached col-
lagen resulted in cellular rounding (data not shown) and a
significant decline in SMC number, whereas inclusion of
exogenous TN-C in the collagen gels prevented this de-
crease (Fig. 3 A) and restored their characteristic elon-
gated morphology (data not shown). Similarly, on floating
collagen, in which MMPs and TN-C expression are sup-
pressed, SMC survival is diminished (Fig. 3 B) via apopto-
sis as determined by oligonucleosomal DNA fragmenta-
tion assays (Fig. 3 C). In contrast, SMC numbers were
unaffected (Fig. 3 B), and apoptosis was suppressed in
cells cultured on floating collagen gels supplemented with
exogenous TN-C protein (Fig. 3 C).
Tenascin-C Collaborates with the avb3 Integrin
to Promote Epidermal Growth Factor–dependent 
Smooth Muscle Cell Proliferation
Tenascin-C has the capacity to bind and interact with mul-
Figure 1. Tenascin-C and matrix metalloproteinase-2 (MMP-2)
expression in vascular smooth muscle cells. (A) Representative
photomicrograph showing SMC morphology on attached type I
collagen gels and on collagen gels that have been released for 2 h
into the culture medium. (B) Autoradiograph (representative of
two different experiments) showing immunoprecipitated TN pro-
tein from [35S]methionine/cysteine-labeled SMC lysates har-
vested from attached and floating type I collagen gels in SFM
with 50 ng/ml EGF at 24 h. Synthesis of two TN-C protein iso-
forms of apparent molecular masses 220 and 180 kD, is sup-
pressed in cells cultured on floating collagen. (C) Gelatin zymog-
raphy was used to examine the levels and activity of gelatinases
present in conditioned medium (CM) harvested from SMCs cul-
tured on attached and floating collagen. Fresh SFM with 50 ng/ml
EGF was added for 4 h before its collection at 4, 8, 12, and 24 h.
Equal volumes of concentrated CM were then analyzed by gela-
tin substrate zymography in nonreducing 10% polyacrylamide
gels containing 0.1% gelatin. A zymogram (representative of
three different experiments) shows that on attached and floating
collagen, SMCs secrete gelatinases with apparent molecular
masses of 68 and 57 kD, and that on floating collagen, the activity
is lower. (D) Densitometry of the 68- and 57-kD gelatinases
shown in C. ( E ) Western immunoblot for the latent form of
MMP-2 in conditioned medium harvested at 24 h from SMCs cul-
tured on attached and floating collagen shows that expression of
the 72-kD proform of this enzyme (equivalent to the 68-kD spe-
cies under nonreducing conditions on the zymogram) is sup-
pressed under floating conditions. Bar, 120 mm.The Journal of Cell Biology, Volume 139, 1997 284
tiple cell surface receptors, including the avb3 integrin
(Prieto et al., 1993; Sriramarao et al., 1993). To determine
whether this integrin mediates TN-C/EGF–dependent
SMC growth, we evaluated the effect of a functional-
blocking anti-avb3 integrin monoclonal antibody (LM609)
on cell morphology and proliferation of SMC cultured on
collagen and TN-C–enriched substrates in the presence of
EGF. While LM609 had no effect on the stellate SMC
morphology observed on collagen, the more elongated
SMC morphology induced by TN-C was attenuated by this
antibody. Instead, SMCs failed to spread and remained
rounded (Fig. 4 A). LM609 had no significant effect on SMC
attachment to TN-C–enriched substrates (Fig. 4 B) or on
cell number after culture of SMC on collagen in the pres-
ence of EGF (Fig. 4 C). In contrast, TN-C–dependent growth
in response to EGF was inhibited by LM609 (Fig. 4 C).
Figure 2. Regulation of tenascin-C protein expression by matrix
metalloproteinases and b3 integrins. (A) Immunoprecipitation of
TN-C protein from [35S]methionine/cysteine-labeled SMCs cul-
tured on native type I collagen gels in serum-free control medium
with 50 ng/ml EGF and 0.4% DMSO, or in control medium sup-
plemented with 1 or 2 mM of GM6001, an MMP inhibitor. Inhibi-
tion of MMP activity with GM6001 leads to a marked decrease in
TN-C protein synthesis. Positions of molecular mass standards in
kD are indicated on the left. (B) Western immunoblotting for
TN-C protein from SMCs cultured in SFM with 50 ng/ml EGF on
native and heat-denatured type I collagen gels. A Western immu-
noblot shows that expression of two TN-C isoforms of apparent
molecular masses 220 and 180 kD is increased in cells cultured on
denatured collagen. (C) Western immunoblot of TN-C protein
from SMCs cultured on heat-denatured type I collagen gels in
control medium supplemented with either 0.4% DMSO or 2 mM
of GM6001. Inhibition of MMP activity with GM6001 had no ef-
fect on TN-C protein expression. (D) Effect of b3 integrin blockade
on TN-C protein expression on heat-denatured collagen. Immu-
noprecipitation of TN-C protein from [35S]methionine/cysteine-
labeled SMCs cultured on native type I collagen gels in the pres-
ence of control IgG or with anti-b3 antibody shows that blocking
b3 integrins inhibits TN-C protein expression on native type I col-
lagen. (E) Effect of b3 integrin blockade on TN-C protein expres-
sion on heat-denatured collagen. Western immunoblot analysis
of lysates derived from cells cultured on heat-denatured collagen
in the presence of control IgG, or with anti-b3 integrin antibody
shows that blocking b3 integrins inhibits TN-C protein expression
on denatured collagen. Arrows indicate the presence of the 220-kD
(upper band) and 180-kD (lower band) TN-C isoforms.
Figure 3. Matrix metalloproteinases and tenascin-C act as vascu-
lar smooth muscle cell survival factors. (A) Smooth muscle cells
(2 3 104 cells per dish) plated on type I collagen were maintained
in serum-free control medium with 0.4% DMSO and 50 ng/ml
EGF, or in control medium supplemented with 1 or 2 mM of
GM6001 and EGF. GM6001 treatment resulted in a significant
decline in SMC numbers by 48 h, whereas addition of exogenous
human TN-C protein (15 mg/ml) to attached collagen substrates
inhibited this effect. (B) Effect of exogenous TN-C on SMC num-
bers on floating collagen gels. A significant decline in SMC num-
bers is apparent on floating compared to attached collagen gels
(P , 0.05), whereas addition of TN-C suppresses this effect. Val-
ues shown in C and D represent mean 6SEM derived from three
experiments. The asterisk denotes a P , 0.05 difference from cell
numbers recorded on collagen gels in EGF-containing medium.
(C) Effect of TN-C on SMC apoptosis on floating collagen gels.
Smooth muscle cells plated on attached type I collagen gels (2 3
104 cells per dish) were maintained in SFM with EGF (50 ng/ml)
for 48 h or were floated in the same medium, either with or with-
out addition of exogenous human TN-C (15 mg/ml). Genomic
DNA was isolated from each culture and 10 mg per sample was
analyzed on 1% agarose gels. DNA fragments comprised of
z180-bp multimers, which are indicative of apoptosis, were ap-
parent on floating collagen gels. In contrast, no evidence of DNA
fragmentation was observed on either attached or TN-C–supple-
mented floating collagen. Positions of a standardized DNA lad-
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Tenascin-C Promotes Accumulation of
F-actin, Tyrosine-phosphorylated Proteins, and
Epidermal Growth Factor Receptors to
the Focal Adhesion Complex
The effects of TN-C–avb3 integrin interactions on SMC
shape and EGF-dependent proliferation provided us with
the rationale for investigating the organization of the fila-
mentous actin cytoskeleton and the distribution of EGF-
Rs and tyrosine-phosphorylated proteins. Accordingly, we
used immunofluorescence microscopy to evaluate the dis-
tribution of F-actin in SMCs cultured on collagen gels sup-
plemented with exogenous TN-C, and we determined
whether this pattern was further altered by EGF (Fig. 5
A). Rhodamine-phalloidin staining revealed a longitudinal
distribution pattern of F-actin stress fibers in SMCs cul-
tured on collagen, which became more cortical after addition
of EGF. On TN-C–supplemented collagen gels, however,
high-intensity F-actin staining was observed at the cell pe-
riphery, and this pattern intensified after addition of EGF.
Given that high-affinity EGF-Rs bind directly to actin
(den Hartigh et al., 1992), we then assessed whether TN-
C–dependent alterations in the organization of the F-actin
cytoskeleton may be accompanied by EGF-R clustering, a
prerequisite for EGF-dependent signaling, including ligand-
dependent tyrosine phosphorylation (Heldin, 1995). Im-
munofluorescent studies revealed a diffuse pattern of
EGF-R staining and tyrosine phosphorylation in SMCs
cultured on collagen alone (Fig. 5 A). By contrast, in
SMCs cultured on TN-C–enriched collagen gels, promi-
nent EGF-R clustering was observed, especially at the cell
periphery. After addition of EGF to collagen gels, a mod-
est increase in both EGF-R clustering and tyrosine phos-
phorylation was apparent, whereas in TN-C–treated cul-
Figure 4. Effect of blocking
avb3 integrins on tenascin-
C–dependent smooth mus-
cle cell morphology, attach-
ment efficiency, and survival.
(A) Representative phase
contrast photomicrographs
of SMCs plated in SFM on
collagen and TN-C–supple-
mented collagen gels with
control IgG (15 mg/ml) or
with an anti–avb3 integrin an-
tisera (LM609; 15 mg/ml).
IgG and LM609 treatment
had no effect on the stellate
morphology produced by the
collagen substrate. In contrast,
the more elongated SMC mor-
phology observed on control-
treated TN-C–enriched sub-
strates was abrogated by
inclusion of LM609, which
prevented cells from spread-
ing, resulting in a rounded
morphology. (B) Effect of
LM609 antisera on SMC at-
tachment to TN-C–supple-
mented type I collagen gels.
By 6 h after plating, no signif-
icant differences in attach-
ment efficiency were noted
between cells plated in SFM
on TN-C–supplemented col-
lagen gels in either the pres-
ence of control IgG or
LM609 antisera. (C) Effect
of blocking SMC avb3 inte-
grins with LM609 antisera on
EGF-dependent SMC cell
growth on TN-C–supple-
mented collagen gels. Con-
trol and LM609 treatment
produced no differences in
SMC number after culture
for 48 h on collagen gels in SFM with 50 ng/ml EGF. The significant (P , 0.05) increase in SMC growth observed on TN-supplemented
collagen gels in the presence of EGF was attenuated by LM609 antisera. Values represent mean 6SEM from three different experi-
ments. (The asterisk denotes P , 0.05 difference from IgG control level on type I collagen.) Bar, 150 mm.The Journal of Cell Biology, Volume 139, 1997 286
tures, EGF-R clustering remained pronounced and high
levels of tyrosine phosphorylation were evident within the
nucleus and at a relatively lower level at the cell periphery.
Furthermore, double immunostaining experiments with an
antivinculin antibody established that TN-C–treated SMCs
contained more focal adhesion complexes, which were
larger than those produced on type I collagen alone (data
not shown). Most strikingly, exogenous TN-C promoted
accumulation of F-actin, EGF-Rs, and tyrosine-phosphor-
ylated proteins within these focal adhesion sites (Fig. 5 B).Jones et al. Smooth Muscle Cell Growth, Tenascin-C, and b3 Integrins 287
Tyrosine Phosphorylation of Epidermal Growth Factor 
Receptors Is Enhanced by Exogenous Tenascin-C
Having established that culturing SMCs on exogenous
TN-C promotes EGF-R clustering, we next determined
the effects of TN-C on EGF-R protein synthesis and ty-
rosine phosphorylation of this receptor. Immunoprecipita-
tion of radiolabeled whole cell lysates with an anti–EGF-R
antibody showed that the levels of receptor protein syn-
thesis were identical on collagen and TN-C–supplemented
gels (Fig. 6 A). Consistent with our immunofluorescent
studies, Western immunoblotting of membrane-enriched
fractions with an antiphosphotyrosine antibody revealed
that there was increased tyrosine phosphorylation in the
presence of exogenous TN-C (Fig. 6 B). In addition, on
both type I collagen and TN-C–supplemented cultures,
Figure 5. Tenascin-C modifies
the patterns of distribution for
filamentous actin, epidermal
growth factor receptors, ty-
rosine-phosphorylated proteins,
and vinculin. (A) Representative
immunofluorescence photomi-
crographs (from two different
experiments) showing distribu-
tion patterns for F-actin, EGF-Rs,
and tyrosine-phosphorylated
(P-Tyr) proteins in SMC cul-
tured in SFM (1/- 50 ng/ml EGF
for 30 min) on collagen alone or
on TN-C (15 mg/ml) supplemented
collagen substrates. Rhodamine-
phalloidin staining of SMC on
collagen revealed a longitudinal
F-actin stress fiber pattern of
distribution that was more corti-
cal after treatment with EGF.
Immunofluorescent staining for
EGF-Rs and tyrosine-phosphory-
lated proteins was diffuse in
SMC cultured on collagen alone
and increased modestly after ad-
dition of EGF. In contrast, SMC
cultured on TN-C–supplemented
collagen gels showed high-inten-
sity F-actin staining in regions
that often overlapped with clus-
ters of EGF-Rs and tyrosine-
phosphorylated proteins. After
addition of EGF to TN-C–treated
cultures, the levels and distribu-
tion of EGF-Rs remained pro-
nounced, and high levels of ty-
rosine-phosphorylated proteins
were evident throughout the
cell. (B) Representative double
immunofluorescence photomi-
crographs showing codistribu-
tion of vinculin, F-actin, EGF-Rs,
and tyrosine-phosphorylated
(P-Tyr) proteins in SMC cul-
tured in SFM on collagen sup-
plemented with exogenous hu-
man TN-C protein. Bars: (A) 20
mm; (B) 5 mm.The Journal of Cell Biology, Volume 139, 1997 288
EGF treatment resulted in a transient increase in protein
tyrosine phosphorylation that was enhanced by TN-C. Of
particular interest was a 170-kD tyrosine-phosphorylated
species that corresponds in molecular mass to the EGF-R.
Also noted was an increase in an z125-kD species, which
may represent focal adhesion kinase (Fig. 6 B). To specifi-
cally determine whether TN-C promotes EGF-R activa-
tion, EGF-Rs were immunoprecipitated from SMC mem-
brane fractions, and their activation status was assessed
using Western immunoblotting with an antiphosphoty-
rosine antibody. This confirmed that EGF-R phosphoryla-
tion occurs by 10 min after addition of EGF, and that this
response is enhanced in TN-C–supplemented as opposed
to SMC cultures on collagen gels alone (Fig. 6 C).
b3 Integrins Regulate Tenascin-C–dependent
Epidermal Growth Factor Receptor Clustering and 
Ligand-dependent Tyrosine Phosphorylation
We next examined the effects of blocking TN-C–b3 inte-
grin SMC interactions on EGF-R clustering and tyrosine
phosphorylation. Smooth muscle cells were preincubated
with an anti–b3 integrin antibody before plating on TN-
C–supplemented collagen gels. As with the avb3 func-
tional-blocking antibody experiments, the anti–b3 integrin
antibody prevented cell spreading on TN-C (data not
shown). We therefore used the anti–b3 integrin antibody
in subsequent studies (although similar results would be
expected with the avb3 antibody, LM609) and showed in-
hibition of TN-C–dependent EGF-R clustering (Fig. 7 A).
Immunoprecipitation of SMC membrane–enriched frac-
tions followed by Western immunoblotting with an an-
tiphosphotyrosine antibody showed that upon addition of
EGF, EGF-R activation on TN-C–enriched collagen sub-
strates was abrogated in cells pretreated with the function-
blocking anti–b3 integrin antibody (Fig. 7 B).
b3 Integrin Cross-Linking Promotes Clustering and 
Activation of Epidermal Growth Factor Receptors
To determine whether clustering of b3 integrins on SMC
surfaces, in the absence of exogenous TN-C, promotes
EGF-R clustering and ligand-dependent phosphorylation
of EGF-Rs, anti–b3 integrin antibody cross-linking studies
were performed. Smooth muscle cells cultured on type I
collagen gels were treated with either a combination of
anti–b3 integrin and secondary goat anti–mouse IgG F(ab9)2
antibodies or with primary mouse monoclonal anti–b3
integrin antibody alone. Immunofluorescent microscopy
revealed extensive b3 integrin clusters on SMC surfaces
treated with primary and secondary antibodies, whereas a
more diffuse pattern of b3 integrins was apparent in cul-
tures treated with primary antibody alone (Fig. 8 A). Im-
munofluorescent microscopy with an anti–EGF-R antibody
demonstrated that cross-linking the b3 integrin receptor
Figure 6. Tenascin-C potentiates ligand-dependent epidermal
growth factor-receptor tyrosine phosphorylation. (A) Effect of
TN-C on EGF-R protein synthesis. Representative autoradio-
graph (from two different experiments) showing immunoprecipi-
tation of EGF-R protein from [35S]methionine-labeled SMCs cul-
tured on native type I collagen gels (1/2 15 mg/ml TN-C) in SFM
indicates that TN-C has no effect on the levels of EGF-R protein
synthesis compared to SMCs cultured on collagen alone. (B) Ef-
fect of TN-C on tyrosine phosphorylation in SMCs cultured on
collagen and TN-C–supplemented gels in SFM, or after addition
of EGF (50 ng/ml) for 10 and 30 min. A Western immunoblot
(representative of two different studies) was performed on mem-
brane-enriched fractions (15 mg per sample) using an antibody
against tyrosine-phosphorylated proteins. Note that relative to
SMCs cultured on collagen alone, contact with exogenous TN-C
led to an increase in basal levels of tyrosine phosphorylation. In
response to EGF, qualitative and quantitative increases in ty-
rosine-phosphorylated proteins were observed on both collagen
and TN-C, with changes being more pronounced on TN-C–enriched
gels, including species at 170 and 125 kD. Positions of molecular
mass standards in kD are indicated on the right. The 170-kD species
may represent the EGF receptor, and the 125-kD species the fo-
cal adhesion kinase. (C) The 170-kD tyrosine-phosphorylated
protein shown in B represents the EGF-R. Epidermal growth fac-
tor receptors were immunoprecipitated from 15 mg of membrane-
enriched SMC fractions in cells cultured as in B. Epidermal
growth factor immunoprecipitates were analyzed for evidence of
tyrosine phosphorylation using Western immunoblotting with an
antiphosphotyrosine antibody. After addition of EGF at 10 min,
a transient increase in the levels of tyrosine-phosphorylated
EGF-Rs occurs on collagen and TN-C–supplemented gels, with
greater levels observed on TN-C–supplemented collagen sub-
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leads to clustering of EGF-Rs, which appeared diffuse in
SMCs treated with primary antibody alone (Fig. 8 A).
To further assess the effect of b3 integrin–dependent
EGF-R clustering on tyrosine phosphorylation of EGF-
Rs, EGF was added to SMCs, which had been pretreated
either with a combination of mouse anti–b3 integrin and
secondary goat anti–mouse IgG F(ab9)2 antibodies, or with
anti–b3 integrin antibody alone. Immunoprecipitation of
EGF-Rs from SMC membrane fractions followed by West-
ern immunoblotting with an antiphosphotyrosine antibody
showed that a significant increase in EGF-dependent acti-
vation of EGF-Rs resulted from cross-linking b3 integrin
receptors (Fig. 8, B and C).
Discussion
A number of studies have described the induction of TN-C
in remodeling vascular tissues, where it has been function-
ally linked to SMC proliferation (Hedin et al., 1991; Hahn
et al., 1995; Chen et al., 1996; Jones and Rabinovitch, 1996;
Jones et al., 1997). However, remarkably little was known
about the nature of the factors that determine its expres-
sion in these tissues or the mechanism by which TN-C sup-
ports SMC growth. In this study, we demonstrate that
MMPs positively regulate TN-C protein expression and
that the mechanism likely involves exposure of cryptic b3
integrin–binding sites in type I collagen. We also show that
TN-C rescues SMCs from apoptosis and promotes EGF-
dependent SMC survival through interactions with the
avb3 integrin receptor, which modulates cell shape and
EGF-dependent tyrosine phosphorylation. These studies
therefore provide new evidence to show how remodeling
of the extracellular microenvironment by ECM-degrading
proteinases may influence integrin growth factor receptor
signaling functions and thus cell behavior. Fig. 9 shows a
hypothetical model for the regulation and function of TN-C
in SMCs based on our findings.
Recent studies by Chiquet-Ehrismann et al. (1994) dem-
onstrated that chick embryo fibroblasts cultured on at-
tached collagen gels express TN-C protein, whereas in
floating cultures, TN-C synthesis is preferentially sup-
pressed. This regulation occurs at the transcriptional level
and was mapped to a putative “ECM response element” in
the TN-C gene promoter that is distinct from the region
important for induction by serum. However, the reason
for this differential TN-C production on attached and
floating collagen and the functional consequences of sup-
pressing TN-C expression were not explored.
It is well established that specific cell–ECM interactions
provide critical cues that regulate proliferation, migration,
differentiation, and cell viability (Jones et al., 1993; Bou-
dreau et al., 1995b), and that these functions may depend
upon proteolysis of ECM and cell surface molecules (Fujii
and Imamaura, 1995; Brooks et al., 1996). Since MMPs
and TN-C are often expressed at the same site within nor-
mal (Sympson et al., 1994; Jones et al., 1995) and injured
remodeling tissues (Latijnhouwers et al., 1996; Vaalamo et
al., 1996), including blood vessels (Bendeck et al., 1994;
Strauss et al., 1996; Jones, P.L., J. Crack, and M. Rabino-
vitch. 1996. Mol. Biol. Cell. 7:418a), we examined the pos-
sibility that MMPs regulate SMC growth and viability
through the induction of TN-C. Accordingly, we estab-
lished a role for MMPs in regulating TN-C expression and
SMC survival by showing that reducing MMP activity and
expression on floating collagen gels, or with a specific
MMP inhibitor, limits TN-C protein synthesis and SMC
growth and survival.
Matrix metalloproteinase–mediated alterations in cell–
ECM interactions have profound effects on receptor-medi-
ated intracellular signaling and subsequent cell behavior
(for review see Bausbaum and Werb, 1996). For example,
MMP-2 exposes cryptic RGD ligands in native collagen,
which may bind avb3 integrins to promote cell survival
(Montgomery et al., 1994), an effect which can be mim-
icked by culturing cells on heat-denatured collagen (Davis,
1992; Montgomery et al., 1994). In the present study, we
Figure 7. The role of b3 integrins in tenascin-C–dependent epi-
dermal growth factor receptor clustering and ligand-dependent
receptor activation. (A) Representative immunofluorescence
photomicrographs for EGF-R in SMCs cultured on TN-C (15 mg/
ml) supplemented collagen gels in the presence of control IgG or
with an anti–b3 integrin antibody that prevented the formation of
EGF-R clusters. (B) Effect of blocking b3 integrins on ligand-
dependent EGF-R tyrosine phosphorylation in SMCs cultured on
collagen gels supplemented with TN-C. Western immunoblot
(representative of two different studies) of membrane prepara-
tions from SMCs treated with control IgG, with anti–b3 integrin
antisera on TN-C–supplemented collagen in SFM alone, or in
SFM with EGF (50 ng/ml) for 10 and 30 min. Epidermal growth
factor receptors were immunoprecipitated from 15 mg of mem-
brane-enriched SMC fractions and were analyzed for evidence of
tyrosine phosphorylation using Western immunoblotting. Note
that the anti–b3 integrin antibody prevents the transient increase
in EGF-R tyrosine phosphorylation observed in TN-treated cul-
tures after addition of EGF at 10 min. Bar, 17 mm.The Journal of Cell Biology, Volume 139, 1997 290
demonstrate that on native type I collagen, MMPs pro-
mote TN-C protein expression via b3 integrins, and using
denatured collagen, we show that this substrate supports
TN-C expression in a manner that still requires b3 inte-
grins but is independent of MMPs. Thus, on attached type I
collagen gels, activated MMPs may generate two RGD-con-
taining ligands, i.e., denatured collagen and TN-C, and in
this way, serve a dual function in cell survival. In addition,
recent studies indicate that MMP-2 directly interacts with
the avb3 integrin receptor to form a functional complex
(Brooks et al., 1996). Since the appearance of TN-C ex-
pression within remodeling tissues is restricted in a precise
spatial manner (Chiquet-Ehrismann et al., 1995), it is also
tempting to speculate that induction of TN-C by MMPs
serves to localize this ECM component with its cognate
adhesion receptors, which include the avb3 integrin (Prieto
et al., 1993; Sriramarao et al., 1993).
Considerable evidence demonstrates that regulation of
cell shape and tissue organization by the ECM profoundly
influences gene expression, differentiation, and growth be-
havior (Folkman and Moscona, 1978; Mooney et al., 1995;
Ingber, 1993; Roskelley et al., 1994; Boudreau et al., 1996;
Chen, 1997; Weaver et al., 1997). Our results show that
suppression of endogenous TN-C occurs within a rounded
SMC population, in which EGF-dependent growth and
survival are limited, whereas addition of exogenous TN-C
Figure 8. Effect of cross-linking b3 integrins on epidermal growth factor receptor clustering. (A) Representative immunofluorescence
micrographs for b3 integrins and EGF-Rs. Smooth muscle cells cultured on collagen substrates in SFM were preincubated for 60 min
with an anti–b3 integrin antibody (150 mg/ml) and then for 60 min with SFM alone or with an anti-F(ab9)2 IgG (20 mg/ml) to promote
cross-linking. Immunodetection of b3 integrins and EGF-Rs indicates that cross-linking b3 integrins promotes EGF-R clustering. (B) Effect
of cross-linking b3 integrins on ligand-dependent tyrosine phosphorylation of EGF-Rs. Tyrosine phosphorylation of EGF-Rs in re-
sponse to EGF was examined in SMC cultures treated with anti–b3 integrin antibody alone or in cultures incubated sequentially with an
anti–b3 integrin antibody and anti-F(ab9)2 IgG. Epidermal growth factor receptor immunoprecipitates were analyzed by Western immu-
noblotting using an antiphosphotyrosine antibody, which indicated that cross-linking b3 integrins potentiates ligand-dependent EGF-R
activation. (C) Densitometry of activated epidermal growth factor Western immunoblots (as shown in B) shows that a significant (*P ,
0.05) increase in ligand-dependent tyrosine phosphorylation occurs after b3 integrin cross-linking. Values represent mean 6SEM from
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to these cultures is associated with the restoration of an elon-
gated cell shape, the reestablishment of an EGF-dependent
growth response, and the prevention of apoptosis. Also,
using functional-blocking anti–b3 integrin antibodies, we
show that EGF-R signaling is attenuated in SMCs that fail
to spread on TN-C–enriched collagen substrates. These
data strongly indicate that TN-C–dependent cell shape al-
terations may impact cell growth and survival functions in
SMCs. Consistent with this idea, suppression of TN-C ex-
pression in mammary epithelial cells is associated with cel-
lular rounding (Jones et al., 1995) and repression of
growth-related genes including c-myc (Boudreau et al.,
1996). Furthermore, we have shown that SMCs plated on
nonadhesive substrates remain rounded and are unable to
proliferate in response to EGF, whereas on tissue culture
plastic, SMC spread and are able to grow (Jones, P.L., and
M. Rabinovitch, unpublished observations).
Our studies comparing SMC growth and survival on at-
tached and floating collagen gels add to previous work
that suggests that mechanical factors are able to modulate
growth factor–dependent functions, by relating this prop-
Figure 9. Hypothetical model for the
regulation and function of tenascin-C
in vascular smooth muscle cells. (A)
Vascular smooth muscle cells attach
and spread on native type I collagen
using b1 integrins. Under serum-free
conditions, the cells withdraw from the
cell cycle and become quiescent. (B)
Degradation of native type I collagen
by matrix metalloproteinases (MMPs)
leads to the exposure of cryptic RGD
sites that preferentially bind b3 sub-
unit–containing integrins. In turn, oc-
cupancy and activation of b3 integrins
signals the production of TN-C. (C) In-
corporation of multivalent TN-C pro-
tein into the underlying substrate leads
to further aggregation and activation
of  b3-containing integrins (avb3), and to
the accumulation of tyrosine-phosphory-
lated (Tyr-P) signaling molecules and
actin into a focal adhesion complex
(FAC). Note that even in the absence
of the EGF ligand, the TN-C–depen-
dent reorganization of the cytoskele-
ton leads to clustering of actin-associ-
ated EGF-Rs. (D) Addition of EGF
ligand to clustered EGF-Rs results in
rapid and substantial tyrosine phos-
phorylation of the EGF-R and activa-
tion of downstream pathways culmi-
nating in the generation of nuclear
signals leading to cell proliferation.
erty to alterations in TN-C expression, and concomitant
changes in cell shape and growth factor receptor activa-
tion. For example, fibroblasts in mechanically stressed col-
lagen continue to proliferate in response to growth factors
(Nakagawa et al., 1989), whereas cells in mechanically re-
laxed matrices become arrested in G0 and are less respon-
sive to addition of serum or purified growth factors (Nishi-
yama et al., 1991). Mechanistically, autophosphorylation
of PDGF and EGF-Rs in fibroblasts is decreased in me-
chanically relaxed collagen (Lin and Grinnell, 1993),
whereas b1 integrin–dependent autophosphorylation of
platelet derived growth factor (PDGF b) receptors is in-
duced in fibroblasts in response to the application of exter-
nal tension (Sundberg and Rubin, 1996). It is therefore
possible that mechanical induction of TN-C and/or other
ECM components might be important in the activation of
a more extensive repertoire of growth factor receptors. In-
deed, we have previously shown that TN-C cooperates
with another soluble growth factor, bFGF, to facilitate
SMC proliferation (Jones and Rabinovitch, 1996). Also,
the cooperative effect between TN-C, EGF, and bFGFThe Journal of Cell Biology, Volume 139, 1997 292
does not appear to be restricted to a single cell type, or cell
surface receptor. Chung et al. (1996) showed that cell sur-
face annexin II, which also acts as a TN-C receptor (Chung
and Erickson, 1995), mediates TN-C/bFGF–dependent
endothelial cell growth, whereas End et al. (1992) showed
that TN-C and EGF stimulate proliferation of Swiss fibro-
blasts, NIH-3T3 cells and SMCs isolated from spontane-
ously hypertensive rats. Our present studies therefore con-
firm the idea that TN-C cooperates with soluble growth
factors to promote cell proliferation and extend these
studies by providing a mechanism for these cooperative ef-
fects that is based on ECM-dependent cell shape changes
and cross-talk between integrins and growth factor signal-
ing pathways.
Binding of EGF to its receptor leads to dimerization,
which is essential to the subsequent activation of intrinsic
tyrosine kinase activity (Schlessinger, 1988). In turn, EGF-R
activation catalyzes the tyrosine phosphorylation of several
protein substrates, including the receptor itself (Hunter
and Cooper, 1988). In the present study, we show for the
first time that the avb3 integrin mediates TN-C/EGF–depen-
dent growth, and that this interaction leads to cell shape
changes that are underscored by a redistribution of fila-
mentous actin, clustering of EGF-Rs, and accumulation of
tyrosine-phosphorylated proteins at the cell periphery
within focal adhesion contacts, as well as increased activa-
tion of EGF-Rs after addition of EGF. Moreover, these
TN-C–dependent effects on EGF-R clustering and ty-
rosine phosphorylation could be mimicked by cross-link-
ing SMC b3 integrins. It is therefore possible that other
ECM components that bind b3 integrins, e.g., vitronectin
and proteolysed collagen, which have also been implicated
in vascular pathobiology (Montgomery et al., 1994; Brooks
et al., 1996), could function in a manner similar to TN-C.
Indeed, a recent report shows that denatured monomeric
collagen stimulates increased focal adhesion contact
formation and PDGF-BB–dependent SMC proliferation
(Koyama et al., 1996), whereas polymerized collagen in-
hibits growth by upregulating cyclin-dependent kinase in-
hibitors including p27kip1 and p21Cip1/Waf1.
Most integrins do not possess intrinsic kinase activity,
and their ability to generate a signal after ligation to ECM
appears to be dependent upon the formation of special-
ized structures comprised of multiple components, includ-
ing clustered integrins, actin, growth factor receptor sig-
naling molecules, and cytoskeletal-associated proteins
such as vinculin and focal adhesion kinase (Miyamoto et
al., 1995a; Plopper et al., 1995; Burridge and Chrza-
nowska-Woodnicka, 1996). In addition, a number of stud-
ies have provided evidence in favor of a direct role for the
actin cytoskeleton in EGF-R signaling. For example, the
EGF-R has been shown to be an actin-binding protein
(den Hartigh et al., 1992), and from a functional stand-
point, this association leads to the accumulation and acti-
vation of EGF-R substrates at the binding site (Gronowski
and Bertics, 1993; Diakonova et al., 1995). However, the
functional consequences of these types of interactions and
the identity of cell surface receptors involved had not been
explored. Our results strongly indicate that ligation of sub-
strate-bound TN-C to SMC avb3 integrins leads to the for-
mation of specialized cytoskeletal structures enriched with
tyrosine-phosphorylated proteins that together favor the re-
cruitment and clustering of actin-associated high-affinity
EGF-Rs. Addition of EGF to these cells, which are now
both physically and biochemically primed, would allow the
generation of an optimal and ECM-specific mitogenic re-
sponse.
In conclusion, our results represent a model for neointi-
mal formation, whereby induction of MMPs upregulates
TN-C expression, which in turn facilitates growth factor–
dependent SMC proliferation. Based on the present studies,
and our work that has linked increased TN-C expression
and SMC proliferation in vivo (Jones and Rabinovitch,
1996; Jones et al., 1997), we suggest that TN-C and its re-
ceptors may be prime therapeutic targets for inhibiting
SMC growth that is associated with vascular disease.
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